阿尼哥医疗 ANIK 深 沪
等待开盘 02-13 09:30:00 美东时间
10.06
-0.190
-1.85%
华盛通- 最 高10.95
- 今 开10.31
- 成交量 8.20万股
- 最 低 9.0101
- 昨 收 10.25
- 总市值 14.63万
- 52周最高 18.07
- 市盈率 静 35.61
- 换手率 563.76%
- 52周最低 7.90
- 委 比 73.16%
- 总股本 1.45万
- 历史最高 75.715
- 量 比 0.66
- 振 幅 18.93%
- 历史最低 1.10
- 每 手 1
- 风险率 2.67%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Anika Therapeutics granted 2,500 stock options to a new employee at $11.45 per share, vesting annually over three years, under its 2021 Inducement Plan.
2025-06-05 21:00
ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
ANI Pharmaceuticals' CEO, Nikhil Lalwani, will present at the 2025 Jefferies Global Healthcare Conference on June 4, 2025, at 2:35pm ET. The live and archived webcast will be available on the Company’s website under the Investors section.
2025-05-27 20:30
ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout Flares
ANI Pharmaceuticals announced a Phase 4 clinical trial comparing two dose levels of Purified Cortrophin Gel for treating acute gout flares, evaluating safety and efficacy.
2025-05-22 10:50
